We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $73.4B Turnover 30.34%
1-Year Est. Return 32.8%
 

Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.

This Fund
S&P 500
This Quarter Est. Return
+11.58%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.33%
AUM
$130B
AUM Growth
+$12B
Cap. Flow
+$2.46B
Cap. Flow %
1.89%
Top 10 Hldgs %
12.68%
Holding
3,913
New
518
Increased
1,835
Reduced
1,085
Closed
442
Avg Time Held
2.5 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.57B
2
TSLA icon
Tesla
TSLA
+$1.06B
3
AMZN icon
Amazon
AMZN
+$597M
4
QCOM icon
Qualcomm
QCOM
+$374M
5
ABBV icon
AbbVie
ABBV
+$373M

Sector Composition

Rank Sector Weight
1 Healthcare 21.63%
2 Technology 13.18%
3 Consumer Discretionary 10.51%
4 Financials 8.74%
5 Communication Services 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BMY icon
1
Bristol-Myers Squibb
BMY
$129B
$3.86B 2.97%
60,210,661
+27,452,891
+84% +$1.57B
2016 Q2
14 quarters
TSLA icon
2
Tesla
TSLA
$1.5T
$1.65B 1.27%
59,072,130
+49,007,115
+487% +$1.06B
2018 Q4
4 quarters
VRSN icon
3
VeriSign
VRSN
$27.7B
$1.59B 1.22%
8,270,690
-11,886
-0.1% -$2.23M
2013 Q2
26 quarters
VRTX icon
4
Vertex Pharmaceuticals
VRTX
$136B
$1.55B 1.19%
7,076,582
+1,277,465
+22% +$259M
2017 Q1
11 quarters
NVO icon
5
Novo Nordisk
NVO
$183B
$1.52B 1.17%
52,434,052
+2,860,620
+6% +$79.2M
2013 Q2
26 quarters
CMG icon
6
Chipotle Mexican Grill
CMG
$45.5B
$1.48B 1.13%
88,177,100
-7,545,000
-8% -$121M
2016 Q4
12 quarters
BIIB icon
7
Biogen
BIIB
$37.2B
$1.36B 1.04%
4,569,906
+348,700
+8% +$96.8M
2018 Q1
7 quarters
PANW icon
8
Palo Alto Networks
PANW
$259B
$1.31B 1.01%
33,974,706
-1,114,194
-3% -$42.1M
2015 Q2
18 quarters
GILD icon
9
Gilead Sciences
GILD
$208B
$1.1B 0.85%
16,962,944
+2,228,686
+15% +$145M
2014 Q4
20 quarters
HUM icon
10
Humana
HUM
$55.4B
$1.08B 0.83%
2,951,242
-5,076
-0.2% -$1.61M
2015 Q2
18 quarters
WMT icon
11
Walmart
WMT
$1.02T
$1.06B 0.82%
26,780,511
+4,842,300
+22% +$192M
2018 Q4
4 quarters
ABBV icon
12
AbbVie
ABBV
$521B
$1.04B 0.8%
11,796,744
+4,490,046
+61% +$373M
2018 Q1
7 quarters
AGN
13
DELISTED
Allergan plc
AGN
$960M 0.74%
5,019,812
+1,345,644
+37% +$243M
2017 Q1
11 quarters
PBR icon
14
Petrobras
PBR
$111B
$904M 0.69%
56,695,930
+13,270,530
+31% +$203M
2016 Q2
14 quarters
GSK icon
15
GSK
GSK
$101B
$894M 0.69%
15,222,079
+1,180,720
+8% +$65.7M
2013 Q2
26 quarters
GE icon
16
GE Aerospace
GE
$337B
$844M 0.65%
15,173,130
+3,090,800
+26% +$160M
2019 Q1
3 quarters
AMGN icon
17
Amgen
AMGN
$250B
$762M 0.59%
3,159,538
-498,548
-14% -$110M
2013 Q2
26 quarters
TEAM icon
18
Atlassian
TEAM
$37.8B
$732M 0.56%
6,081,924
+630,125
+12% +$76.7M
2016 Q2
14 quarters
ALGN icon
19
Align Technology
ALGN
$11.7B
$729M 0.56%
2,610,848
+394,948
+18% +$98.5M
2013 Q2
26 quarters
MNST icon
20
Monster Beverage
MNST
$89.7B
$728M 0.56%
45,809,260
+7,737,244
+20% +$114M
2014 Q1
23 quarters
TGT icon
21
Target
TGT
$72.8B
$727M 0.56%
5,671,968
+1,517,068
+37% +$178M
2019 Q1
3 quarters
HSY icon
22
Hershey
HSY
$35.1B
$660M 0.51%
4,491,062
-337,853
-7% -$50.1M
2013 Q2
26 quarters
VOD icon
23
Vodafone
VOD
$35.5B
$657M 0.5%
33,972,220
+4,649,003
+16% +$92.6M
2015 Q3
17 quarters
META icon
24
Meta Platforms (Facebook)
META
$1.6T
$649M 0.5%
3,159,939
-1,780,294
-36% -$345M
2018 Q2
6 quarters
BP icon
25
BP
BP
$116B
$645M 0.5%
17,090,262
-708,400
-4% -$26.9M
2017 Q2
10 quarters

Similar funds

Renaissance Technologies's Q4 2019 Portfolio in Review

As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Renaissance Technologies's Q4 2019 filing shows 518 new, 1,835 increased, 1,085 reduced and 442 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene, an estimated $1.54B.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
  • Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
  • Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
  • Renaissance Technologies fully exited Celgene in Q4 2019, selling an estimated $1.54B.
  • Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
  • Renaissance Technologies opened 518 new positions and closed 442 in Q4 2019.
  • Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.